Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “formulation”

865 pharma patents match "formulation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 865
Index total 30,257
Page 9 / 37

Quick answer

This filtered view shows 865 pharmaceutical patents matching "formulation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

865 results for “formulation” · 30,257 patents in full index Clear search

  1. US 11576871

    Formulations of cysteamine and cystamine

    The Regents of the University of California · Granted Feb 14, 2023 · Expires Feb 9, 2043

    granted
  2. US 11564979

    Stabilized liquid and lyophilized ADAMTS13 formulations

    Takeda Pharmaceutical Company Limited · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  3. US 11559484

    Film formulations containing dexmedetomidine and methods of producing them

    BioXcel Therapeutics, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  4. US 11547683

    Therapeutic compounds, formulations, and uses thereof

    Tvardi Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  5. US 11541125

    Noncrushable pill formulations

    The Regents of the University of California · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  6. US 11529360

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  7. US 11529298

    Cosmetic composition and its use, dermocosmetic formulation

    LUXBIOTECH FARMACÉUTICA LTDA · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  8. US 11523981

    Cosmetic composition and its use, dermocosmetic formulation

    LUXBIOTECH FARMACÉUTICA LTDA · Granted Dec 13, 2022 · Expires Dec 8, 2042

    granted
  9. US 11517524

    Film formulations containing dexmedetomidine and methods of producing them

    BioXcel Therapeutics, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  10. US 11510984

    Anhydrous sodium thiosulfate and formulations thereof

    Fennec Pharmaceuticals, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

    granted
  11. US 11505564

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  12. US 11497711

    Film formulations containing dexmedetomidine and methods of producing them

    BioXcel Therapeutics, Inc. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted
  13. US 11499166

    Adeno-associated variants, formulations and methods for pulmonary delivery

    4D MOLECULAR THERAPEUTICS INC. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted
  14. CN 115348859

    Ophthalmic formulations comprising n-[5-(aminosulfonyl)-4-methyl-1, 3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl) phenyl] acetamide hemihydrate

    BAYER HEALTHCARE AG · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted
  15. US 11491125

    Baclofen formulations and methods of minimizing patient exposure to metabolite variations

    AMNEAL PHARMACEUTICALS LLC · Granted Nov 8, 2022 · Expires Nov 3, 2042

    granted
  16. US 11484591

    Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 1, 2022 · Expires Oct 27, 2042

    granted
  17. US 11478422

    Film formulations containing dexmedetomidine and methods of producing them

    BioXcel Therapeutics, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  18. US 11464764

    Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound

    Corcept Therapeutics Incorporated · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  19. US 11458136

    Antiviral prodrugs and formulations thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  20. US 11452721

    Formulations of pimavanserin

    ACADIA Pharmaceuticals Inc. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  21. US 11446310

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  22. US 11447510

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  23. US 11446383

    Lipid formulations for delivery of therapeutic agents

    ARBUTUS BIOPHARMA CORPORATION · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted
  24. US 11439597

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    AXSOME MALTA LTD. · Granted Sep 13, 2022 · Expires Sep 8, 2042

    granted